INNOCARE PHARMA LTD revenue for the last year amounted to 1.01 B CNY, the most of which — 1.01 B CNY — came from its highest performing source at the moment, Biopharmaceutical Research and Development, Manufacturing, Commercialization and Service, the year earlier bringing 738.54 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought INNOCARE PHARMA LTD 1.01 B CNY, and the year before that — 673.13 M CNY.